Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Oct;67(792):938–946. doi: 10.1136/pgmj.67.792.938

Hypertension in non-insulin dependent diabetes mellitus and its management.

M D Feher 1
PMCID: PMC2399178  PMID: 1758808

Full text

PDF
938

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barret-Connor E., Criqui M. H., Klauber M. R., Holdbrook M. Diabetes and hypertension in a community of older adults. Am J Epidemiol. 1981 Mar;113(3):276–284. doi: 10.1093/oxfordjournals.aje.a113097. [DOI] [PubMed] [Google Scholar]
  2. Bröchner-Mortensen J. Glomerular filtration rate and extracellular fluid volumes during normoglycemia and moderate hyperglycemia in diabetics. Scand J Clin Lab Invest. 1973 Dec;32(4):311–316. doi: 10.3109/00365517309084353. [DOI] [PubMed] [Google Scholar]
  3. Christensen C. K., Mogensen C. E. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabet Med. 1985 Mar;2(2):97–102. doi: 10.1111/j.1464-5491.1985.tb00608.x. [DOI] [PubMed] [Google Scholar]
  4. Cowie C. C., Port F. K., Wolfe R. A., Savage P. J., Moll P. P., Hawthorne V. M. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989 Oct 19;321(16):1074–1079. doi: 10.1056/NEJM198910193211603. [DOI] [PubMed] [Google Scholar]
  5. DeFronzo R. A. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981 Sep;21(3):165–171. doi: 10.1007/BF00252649. [DOI] [PubMed] [Google Scholar]
  6. Dupree E. A., Meyer M. B. Role of risk factors in complications of diabetes mellitus. Am J Epidemiol. 1980 Jul;112(1):100–112. doi: 10.1093/oxfordjournals.aje.a112959. [DOI] [PubMed] [Google Scholar]
  7. Eckberg D. L., Harkins S. W., Fritsch J. M., Musgrave G. E., Gardner D. F. Baroreflex control of plasma norepinephrine and heart period in healthy subjects and diabetic patients. J Clin Invest. 1986 Aug;78(2):366–374. doi: 10.1172/JCI112586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fabre J., Balant L. P., Dayer P. G., Fox H. M., Vernet A. T. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int. 1982 May;21(5):730–738. doi: 10.1038/ki.1982.90. [DOI] [PubMed] [Google Scholar]
  9. Feher M. D., Henderson A. D., Wadsworth J., Poulter C., Gelding S., Richmond W., Sever P. S., Elkeles R. S. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens. 1990 Oct;4(5):571–577. [PubMed] [Google Scholar]
  10. Feher M. D., Rains S. G., Richmond W., Torrens D., Wilson G., Wadsworth J., Sever P. S., Elkeles R. S. Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J. 1988 Dec;64(758):926–930. doi: 10.1136/pgmj.64.758.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feher M. D., Rampling M. W., Sever P. S., Elkeles R. S. Diabetic hypertension--the importance of fibrinogen and blood viscosity. J Hum Hypertens. 1988 Aug;2(2):117–122. [PubMed] [Google Scholar]
  12. Feher M. D., Torrens D. J., Richmond W., Wadsworth J., Sever P. S., Elkeles R. S. Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes. J Hum Hypertens. 1988 Dec;2(4):253–255. [PubMed] [Google Scholar]
  13. Feldt-Rasmussen B., Mathiesen E. R., Deckert T., Giese J., Christensen N. J., Bent-Hansen L., Nielsen M. D. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987 Aug;30(8):610–617. doi: 10.1007/BF00277316. [DOI] [PubMed] [Google Scholar]
  14. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  16. Goodkin G. Mortality factors in diabetes. A 20 year mortality study. J Occup Med. 1975 Nov;17(11):716–721. [PubMed] [Google Scholar]
  17. Gottlieb M. S. The natural history of diabetes: factors present at time of diagnosis which may be predictive of length of survival. J Chronic Dis. 1974 Nov;27(9-10):435–445. doi: 10.1016/0021-9681(74)90037-x. [DOI] [PubMed] [Google Scholar]
  18. Holm G. Adrenergic regulation of insulin release. Acta Med Scand Suppl. 1983;672:21–25. doi: 10.1111/j.0954-6820.1983.tb01609.x. [DOI] [PubMed] [Google Scholar]
  19. Janka H. U., Standl E., Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique. Diabetes Care. 1980 Mar-Apr;3(2):207–213. doi: 10.2337/diacare.3.2.207. [DOI] [PubMed] [Google Scholar]
  20. Jarrett R. J., McCartney P., Keen H. The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 1982 Feb;22(2):79–84. doi: 10.1007/BF00254833. [DOI] [PubMed] [Google Scholar]
  21. Kannel W. B., McGee D. L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979 Mar-Apr;2(2):120–126. doi: 10.2337/diacare.2.2.120. [DOI] [PubMed] [Google Scholar]
  22. Kannel W. B. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983 Sep 26;75(3A):4–11. doi: 10.1016/0002-9343(83)90111-0. [DOI] [PubMed] [Google Scholar]
  23. Kaplan N. M. Management of low-renin hypertension. Am J Kidney Dis. 1989 Jun;13(6 Suppl 1):2–7. [PubMed] [Google Scholar]
  24. Keen H., Track N. S., Sowry G. S. Arterial pressure in clinically apparent diabetics. Diabete Metab. 1975 Sep;1(3):159–178. [PubMed] [Google Scholar]
  25. Kelleher C., Kingston S. M., Barry D. G., Cole M. M., Ferriss J. B., Grealy G., Joyce C., O'Sullivan D. J. Hypertension in diabetic clinic patients and their siblings. Diabetologia. 1988 Feb;31(2):76–81. doi: 10.1007/BF00395551. [DOI] [PubMed] [Google Scholar]
  26. Kendall M. J. Are selective beta-adrenoceptor blocking drugs an advantage? J R Coll Physicians Lond. 1981 Jan;15(1):33–40. [PMC free article] [PubMed] [Google Scholar]
  27. Klein R., Klein B. E., Moss S. E., DeMets D. L. Blood pressure and hypertension in diabetes. Am J Epidemiol. 1985 Jul;122(1):75–89. doi: 10.1093/oxfordjournals.aje.a114088. [DOI] [PubMed] [Google Scholar]
  28. Knowler W. C., Bennett P. H., Ballintine E. J. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med. 1980 Mar 20;302(12):645–650. doi: 10.1056/NEJM198003203021201. [DOI] [PubMed] [Google Scholar]
  29. Krolewski A. S., Canessa M., Warram J. H., Laffel L. M., Christlieb A. R., Knowler W. C., Rand L. I. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988 Jan 21;318(3):140–145. doi: 10.1056/NEJM198801213180303. [DOI] [PubMed] [Google Scholar]
  30. Laakso M., Rönnemaa T., Pyörälä K., Kallio V., Puukka P., Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988 Jun;11(6):449–463. doi: 10.2337/diacare.11.6.449. [DOI] [PubMed] [Google Scholar]
  31. Letcher R. L., Chien S., Pickering T. G., Sealey J. E., Laragh J. H. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med. 1981 Jun;70(6):1195–1202. doi: 10.1016/0002-9343(81)90827-5. [DOI] [PubMed] [Google Scholar]
  32. Lundgren H., Björkman L., Keiding P., Lundmark S., Bengtsson C. Diabetes in patients with hypertension receiving pharmacological treatment. BMJ. 1988 Dec 10;297(6662):1512–1512. doi: 10.1136/bmj.297.6662.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  34. Messerli F. H., Oren S., Grossman E. Left ventricular hypertrophy and antihypertensive therapy. Drugs. 1988;35 (Suppl 5):27–33. doi: 10.2165/00003495-198800355-00004. [DOI] [PubMed] [Google Scholar]
  35. Murphy M. B., Lewis P. J., Kohner E., Schumer B., Dollery C. T. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet. 1982 Dec 11;2(8311):1293–1295. doi: 10.1016/s0140-6736(82)91506-9. [DOI] [PubMed] [Google Scholar]
  36. Nash D. T., Schonfeld G., Reeves R. L., Black H., Weidler D. J. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension. Am J Cardiol. 1987 May 29;59(14):87G–90G. doi: 10.1016/0002-9149(87)90164-0. [DOI] [PubMed] [Google Scholar]
  37. Oakley W. G., Pyke D. A., Tattersall R. B., Watkins P. J. Long-term diabetes. A clinical study of 92 patients after 40 years. Q J Med. 1974 Jan;43(169):145–156. [PubMed] [Google Scholar]
  38. Pacy P. J., Dodson P. M., Beevers M., Fletcher R. F., Taylor K. G. Prevalence of hypertension in white, black and Asian diabetics in a district hospital diabetic clinic. Diabet Med. 1985 Mar;2(2):125–130. doi: 10.1111/j.1464-5491.1985.tb00615.x. [DOI] [PubMed] [Google Scholar]
  39. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987 Mar;30(3):123–131. doi: 10.1007/BF00274216. [DOI] [PubMed] [Google Scholar]
  40. Parillo M., Coulston A., Hollenbeck C., Reaven G. Effect of a low fat diet on carbohydrate metabolism in patients with hypertension. Hypertension. 1988 Mar;11(3):244–248. doi: 10.1161/01.hyp.11.3.244. [DOI] [PubMed] [Google Scholar]
  41. Parving H. H., Andersen A. R., Smidt U. M., Christiansen J. S., Oxenbøll B., Svendsen P. A. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes. 1983 May;32 (Suppl 2):83–87. doi: 10.2337/diab.32.2.s83. [DOI] [PubMed] [Google Scholar]
  42. Parving H. H., Hommel E. Prognosis in diabetic nephropathy. BMJ. 1989 Jul 22;299(6693):230–233. doi: 10.1136/bmj.299.6693.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Parving H. H., Mogensen C. E., Jensen H. A., Evrin P. E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet. 1974 Jun 15;1(7868):1190–1192. doi: 10.1016/s0140-6736(74)91002-2. [DOI] [PubMed] [Google Scholar]
  44. Pell S., D'Alonzo C. A. Some aspects of hypertension in diabetes mellitus. JAMA. 1967 Oct 2;202(1):104–110. doi: 10.1001/jama.202.1.104. [DOI] [PubMed] [Google Scholar]
  45. Pollare T., Lithell H., Selinus I., Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia. 1988 Jul;31(7):415–420. doi: 10.1007/BF00271585. [DOI] [PubMed] [Google Scholar]
  46. Pollare T., Lithell H., Selinus I., Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ. 1989 Apr 29;298(6681):1152–1157. doi: 10.1136/bmj.298.6681.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia. 1985 Sep;28 (Suppl):615–640. doi: 10.1007/BF00290267. [DOI] [PubMed] [Google Scholar]
  48. Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  49. Roehmholdt M. E., Palumbo P. J., Whisnant J. P., Elveback L. R. Transient ischemic attack and stroke in a community-based diabetic cohort. Mayo Clin Proc. 1983 Jan;58(1):56–58. [PubMed] [Google Scholar]
  50. Shapiro L. M. Specific heart disease in diabetes mellitus. Br Med J (Clin Res Ed) 1982 Jan 16;284(6310):140–141. doi: 10.1136/bmj.284.6310.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Skarfors E. T., Lithell H. O., Selinus I., Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ. 1989 Apr 29;298(6681):1147–1152. doi: 10.1136/bmj.298.6681.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Smith E. B. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 1986 May;15(2):355–370. [PubMed] [Google Scholar]
  53. Sowers J. R., Levy J., Zemel M. B. Hypertension and diabetes. Med Clin North Am. 1988 Nov;72(6):1399–1414. doi: 10.1016/s0025-7125(16)30714-3. [DOI] [PubMed] [Google Scholar]
  54. Sprafka J. M., Bender A. P., Jagger H. G. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care. 1988 Jan;11(1):17–22. doi: 10.2337/diacare.11.1.17. [DOI] [PubMed] [Google Scholar]
  55. Stone M. C., Thorp J. M. Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract. 1985 Dec;35(281):565–569. [PMC free article] [PubMed] [Google Scholar]
  56. Stout R. W. Insulin and atheroma--an update. Lancet. 1987 May 9;1(8541):1077–1079. doi: 10.1016/s0140-6736(87)90495-8. [DOI] [PubMed] [Google Scholar]
  57. Tedde R., Sechi L. A., Marigliano A., Pala A., Scano L. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens. 1989 Mar;2(3 Pt 1):163–170. doi: 10.1093/ajh/2.3.163. [DOI] [PubMed] [Google Scholar]
  58. Uusitupa M., Siitonen O., Pyörälä K., Aro A., Hersio K., Penttilä I., Voutilainen E. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia. 1985 Sep;28(9):653–659. doi: 10.1007/BF00291970. [DOI] [PubMed] [Google Scholar]
  59. Vaishnava H., Bhasin R. C. Hypertension in Indian diabetics. J Chronic Dis. 1969 Feb;21(9):691–702. doi: 10.1016/0021-9681(69)90041-1. [DOI] [PubMed] [Google Scholar]
  60. Viberti G. C. Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus. Am J Kidney Dis. 1989 Jan;13(1):41–44. doi: 10.1016/s0272-6386(89)80114-3. [DOI] [PubMed] [Google Scholar]
  61. Walker W. G., Hermann J., Codd T., Russell R. P. Role of hypertension in diabetic renal disease. Md Med J. 1988 May;37(5):363–367. [PubMed] [Google Scholar]
  62. Weidmann P., Beretta-Piccoli C., Keusch G., Glück Z., Mujagic M., Grimm M., Meier A., Ziegler W. H. Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med. 1979 Nov;67(5):779–784. doi: 10.1016/0002-9343(79)90734-4. [DOI] [PubMed] [Google Scholar]
  63. Weidmann P., Ferrier C., Saxenhofer H., Uehlinger D. E., Trost B. N. Serum lipoproteins during treatment with antihypertensive drugs. Drugs. 1988;35 (Suppl 6):118–134. doi: 10.2165/00003495-198800356-00017. [DOI] [PubMed] [Google Scholar]
  64. Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]
  65. Yarnell J. W., Sweetnam P. M., Elwood P. C., Eastham R., Gilmour R. A., O'Brien J. R., Etherington M. D. Haemostatic factors and ischaemic heart disease. The Caerphilly study. Br Heart J. 1985 May;53(5):483–487. doi: 10.1136/hrt.53.5.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zavaroni I., Dall'Aglio E., Bonora E., Alpi O., Passeri M., Reaven G. M. Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med. 1987 Oct;83(4):609–612. doi: 10.1016/0002-9343(87)90887-4. [DOI] [PubMed] [Google Scholar]
  67. Zemel M. B., Bedford B. A., Zemel P. C., Marwah O., Sowers J. R. Altered cation transport in non-insulin-dependent diabetic hypertension: effects of dietary calcium. J Hypertens Suppl. 1988 Dec;6(4):S228–S230. doi: 10.1097/00004872-198812040-00068. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES